venetoclax,ponatinib
roche,otsuka,incyte,takeda,abbvie
['ponatinib', 'venetoclax']
 phase i is the make or break, the idea of "maximal tolerated dose" probably gives too much dose to the patient and keeps getting safety signals. may be we should strive for a lower dose than to do later trials like 7+7 for venetoclax or 15 mg of ponatinib. #ash22
?????????? HO @Roswellpark. Founder @hemoncfellows past @ahnimres @KEMULahore ???? PCT, AFC, LQ, Steelers ?????????????|?? ??? ??? ???? ???? ?????? ????